1 recruiting. 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 1 | Recruiting 1 |
Follow Oral Paclitaxel Solution: new trials by email Literature Review of Oral Paclitaxel Solution trials Research Report on Oral Paclitaxel Solution
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Oral Paclitaxel Solution With Immunotherapy and Concurrent SBRT as Neoadjuvant Treatment for Older Adults With NSCLC Oral Paclitaxel Solution, PD-1/PD-L1 inhibitor, Stereotactic Body Radiotherapy (SBRT) - NSCLC (Non-small Cell Lung Cancer) | Phase 4 | Recruiting | Shanghai Pulmonary Hospital, Shanghai, China | 78 | 2026-06-25 | 2026-08-10 |
Carcinoma, Non-Small-Cell Lung (1) · Pathologic Complete Response (1)
Shanghai Pulmonary Hospital, Shanghai, China (1)
China (1)
PMID 33096027, PMID 34086039, PMID 37478883, PMID 38512301, PMID 38610980, PMID 39305910, PMID 39614293